Although many retrospective studies have reported that GGO was more frequent in tumors with EGFR mutation [28, 37, 39–41], this meta-analysis revealed that NSCLC with or without GGO did not differ in terms of their EGFR mutation status. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.